Loading...

Bristol-Myers Squibb Company Ce

CELG-RI•NYSE
Healthcare
Drug Manufacturers - General
$0.03
$0.00(0.34%)

Bristol-Myers Squibb Company Ce (CELG-RI) Stock Chart & Performance Analysis

Explore Bristol-Myers Squibb Company Ce’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
9.24%
5-Day Change
9.86%
1-Month Change
-22.00%
3-Month Change
-10.96%
6-Month Change
-2.74%
Year-to-Date (YTD) Change
-20.73%
1-Year Change
-29.09%
3-Year Change
-74.82%
5-Year Change
-74.82%
All-Time (Max) Change
-74.82%

Analyzing Bristol-Myers Squibb Company Ce (CELG-RI) Trends Across Multiple Time Frames

Bristol-Myers Squibb Company Ce Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Bristol-Myers Squibb Company Ce stock shows 9.24% 1-day change, indicating immediate volatility, while its 5-day change of 9.86% suggests a broader trend. Over a 1-month period, a -22.00% drop could signal a pullback, whereas a 3-month decline of -10.96% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -2.74% and a YTD drop of -20.73% might concern investors, but a 1-year loss of -29.09% and a 3-year drop of -74.82% could indicate resilience. The 5-year surge of -74.82% highlights weak historical growth, while the all-time return of -74.82% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;